Peer Review, UGC Care
PREPARATION AND IN VITRO EVALUATION OF HYDROXY PROPYL METHYLCELLULOSE FILMS FOR TRANSDERMAL DELIVERY OF SERTRALINE HYDROCHLORIDE
View PDF

Keywords

Transdermal delivery, Sertraline hydrochloride, HPMC, PEG 400, In vitro evaluation.

How to Cite

Vijaya R, & Bhalamurugan G L. (2015). PREPARATION AND IN VITRO EVALUATION OF HYDROXY PROPYL METHYLCELLULOSE FILMS FOR TRANSDERMAL DELIVERY OF SERTRALINE HYDROCHLORIDE. International Journal of Research and Development in Pharmacy & Life Sciences, 4(4), 1673-1678. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/457

Abstract

The study was aimed to develop hydroxy propyl methylcellulose (HPMC) based matrix type transdermal film for the antidepressant sertraline hydrochloride(SH) to avoid systemic side effects and gastric disorders after oral administration Polymeric grades HPMC K4M, HPMC K15M, HPMC K100M and solvents such as acetone, ethanol and isopropyl alcohol were used in the preparation of film (S1 to S9) by solvent evaporation method. Polyethylene glycol 400 was added as a plasticizer at a concentration of 150% w/w of polymer. Permeation enhancers of propylene glycol and oleic acid were employed to enhance the skin permeation of SH. The films were evaluated in vitro for thickness, folding endurance, percentage moisture absorption, percentage moisture loss, water vapour transmission, tensile strength, drug content, in vitro release and skin permeation. Maximum SH release of 39.94%±0.543% was obtai ned for HPMC K15M formulation (S4) prepared using acetone and water as solvents at a ratio of 9:1. The permeation of SH across the rat abdominal skin was 20.27%±0.051% and was increased to 38.19%±0.063% in the presence of permeation enhancers oleic acid (1%) and propylene glycol (30%) at a rati o of 1:5.The optimized film S4 did not produce any noticeable skin reactions. The drug release followed higuchi kinetics with non fickian diffusion mechanism. In conclusion, the polymer grades of HPMC containing plasticizer had influenced the SH release profile and the incorporation of permeation enhancers increased the permeation of SH.

View PDF

References

Mamatha T, Venkateshwara rao J, Mukkanti K. Ramesh

G. (2009) Current trends in biotechnology and pharmacy. 3(2): 1-16.

Ashvini S Kadam, Mukesh P Ratnaparkhi, Shilpa P Chaudhary. (2014) Int. J. Res. Dev. Pharm. L. Sci. 3(4): 1042-1053.

Vijaya R, Ruckmani K. (2011) DARU. 19(6): 424 - 432.

Narashima Murthy S, Shobha Rani R, Hiremath. (2002) AAPS Pharm Sci Tech. 2(1): 1-5.

Sanjay Dey, Annaya Malgope. (2010)Int. J. Phram. Pharmaceu. Sci. 2(1): 137-142.

Qing Li, Hiroyuki, Tsuji, Yukio, Kato, Yoshimichi, Sai, Yoshiyuki, Kubo, Akira, Tsuji. (2006) J. Control. Rel. 110: 542-546.

Ramesh Gannu, Vamshi Vishnu Y, Kishan V, Madhusudhan Rao Y. (2007) Curr. Drug Deliv. 4: 69-76.

Chandak AR, Priya Ranjan, Prasad Verma. (2008) Journal of the Pharmaceutical Society of Japan. 128(7): 1057-66.

Shaila Lewis, Pandey S, Udupa N. (2006) Ind. J.of Pharm. Sci. 68: 179-184.

Satyanarayan Pattnai K, Kalpana Swain, Subarata Mallick, Zhiqun Lin. (2011) Int.J.Pharm. 406: 106-110.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array

Downloads

Download data is not yet available.